Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 29 of TScan Therapeutics, Inc.'s SEC filings and found 4 warrant series, 1 convertible, 1 ATM program and 4 shelf registrations on file for TCRX. The latest dilution event on file is ATM sales on Aug 12, 2026. Analysis updated Oct 4, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
DAREDare Bioscience, Inc.
HINDVyome Holdings, Inc.
SYBXSynlogic, Inc.
CLRBCellectar Biosciences, Inc.
PBMPsyence Biomedical Ltd.
BIVIBioVie Inc.
LPCNLipocine Inc.
BCDABioCardia, Inc.
GUTSFractyl Health, Inc.
LSTALisata Therapeutics, Inc.
KTTAPasithea Therapeutics Corp.
DYAIDyadic International, Inc.
CTXRCitius Pharmaceuticals, Inc.
INTSIntensity Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.